Massive study checks cancer risk for common arthritis drug
NCT ID NCT05413044
Summary
This study tracked over 140,000 people in Sweden with rheumatoid or psoriatic arthritis to see if the drug abatacept affects their risk of developing cancer. Researchers compared cancer rates in people taking abatacept to those taking other standard arthritis medications. The goal was to gather real-world safety information after the drug was already approved and widely used.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Local Institution
Princeton, New Jersey, 08540, United States
Conditions
Explore the condition pages connected to this study.